OCUL
$5.15
Ocular Therapeut
$.37
7.74%
OCUL
Earnings Whisper ®
N/A
1st Quarter March 2020
Consensus:  ($0.37)
Revenue:  $3.09 Mil
Thursday
Jun 11
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when OCUL reports earnings?
Beat
Meet
Miss

Where is OCUL's stock price going from here?
Up
Flat
Down
Stock chart of OCUL
Analysts
Summary of analysts' recommendations for OCUL
Score
Grade
Pivots
Resistance
$5.15
$4.98
$4.88

$4.71

Support
$4.61
$4.44
$4.34
Tweet
Growth
Description
Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular Therapeutix, Inc. is headquartered in Bedford, Massachusetts.
Peers
BioMarin PharmaceuticalRegeneron PharmaceuticalsVertex PharmaceuticalsJohnson & JohnsonInterCeptZoetisBristol-Myers SquibbMylanUltragenyx PharmaceuticalAlkermes